## Background: Inhibition of apoptosis, or programmed cell death, may be critical both in the development of cancer and in determining response to therapy. the authors examined the expression of two related apoptotic inhibitors, bcl-2 and bcl-xl, in pretreatment biopsies from a series of 42 patient
Differential expression of c-jun and c-fos mRNAs in squamous cell carcinoma of the head and neck: Associations with uPA, gelatinase B, and matrilysin mRNAs
✍ Scribed by Mercia Medeiros Pacheco; Luis Paulo Kowalski; Ines Nobuko Nishimoto; Maria Mitzi Brentani
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 394 KB
- Volume
- 24
- Category
- Article
- ISSN
- 1043-3074
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Background
Head and neck squamous cell carcinomas (HNSCC) are known for their invasive behavior. The invasiveness of these tumors requires proteases, some of which as urokinase‐type plasminogen activator (uPA), gelatinase B and matrilysin are regulated through AP‐1 dependent transcriptional mechanisms. AP‐1 consists of several proteins, including those encoded by the proto‐oncogenes c‐jun and c‐fos. The aim of this study was to: first, evaluate the expression levels of matrix metalloproteases (matrilysin and gelatinase B) and uPA mRNAs; second, examine whether these genes might be associated with c‐jun and c‐fos expression; third, examine the relationship between the expression of these genes and HNSCC clinico‐pathological features.
Methods
We have analyzed 38 HNSCC primary tumors and matched mucosa tissues for uPA, gelatinase B, matrilysin, c‐fos, and c‐jun by Northern‐blot analysis.
Results
uPA, gelatinase B, matrilysin, and c‐jun mean levels were statistically higher in the tumors than in the normal adjacent mucosa, whereas no difference was found when c‐fos mRNA values were compared, c‐jun mRNA expression correlated directly with gelatinase B and matrilysin mRNA levels, but no association with uPA mRNA was observed, c‐fos mRNA levels were not associated with the tested proteases, but low levels were determined in tumors from older patients who subsequently developed a 2^nd^ tumor. No evidence of correlation between expression of uPA, matrilysin, and c‐jun in tumors and clinico‐pathological features was found. Gelatinase B mRNA high levels were associated to presence of cervical recurrences.
Conclusion
Expression of c‐jun seems to be involved in the regulation of gelatinase B and matrilysin being not related to uPA. Lack of association with c‐fos may indicate that other fos family members might play a role in the transcriptional activity of the analyzed proteases in HNSCC tumors. © 2002 John Wiley & Sons, Inc. Head Neck 24: 24–32, 2002.
📜 SIMILAR VOLUMES
Hypercalcemia is a well-recognized phenomenon in squamous cell carcinoma of the head and neck, but the incidence of hypercalcemia in this group of patients is not clear. We have reviewed the records of 166 patients with squamous cell carcinoma of the head and neck presented at the Boston VA Medical
## Abstract ## Background and Methods. VEGF proteins and their receptors are involved in tumor vessel neoformation. The third VEGF receptor, VEGFR3 (flt‐4) is important during both blood vessel development and lymphatic vessel formation. Because HNSCC preferentially metastasizes to regional lymph
## Abstract ## __Background.__ Perineural invasion (PNI) in cutaneous squamous cell carcinoma of the head and neck (CSCCHN) is associated with decreased survival, particularly in patients with clinical signs of cranial nerve involvement. There is evidence to indicate that neural cell adhesion mole
## Abstract ## BACKGROUND: Recent genetic studies have implicated p53 mutation as a significant risk factor for therapeutic failure in squamous cell carcinoma of the head and neck (SCCHN). However, in a recent meta‐analysis in the literature of p53 from major anatomical subsites (larynx, oral cavi
To determine the relationship between p16 MTS1/CDK4I expression, gene inactivation and 9p21 loss of heterozygosity (LOH) in the development of laryngeal carcinomas, we have examined p16 MTS1/CDK4I protein and mRNA expression in a series of 7 normal and 36 tumoral tissues, and the presence of gene al